Loading...
Loading...
NVNO| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 141.0K |
| Gross Profit | -141.0K |
| Operating Expense | 5,362.0K |
| Operating I/L | -5,503.0K |
| Other Income/Expense | 511.0K |
| Interest Income | 59.0K |
| Pretax | -4,992.0K |
| Income Tax Expense | 97.7K |
| Net Income/Loss | -4,992.0K |
enVVeno Medical Corporation is a medical device company specializing in bioprosthetic tissue-based solutions for venous diseases. Their lead product, the VenoValve, is a surgical implant designed to treat severe deep venous chronic venous insufficiency by restoring proper blood flow in the leg. The VenoValve is implanted in the femoral vein and acts as a one-way valve. The company generates revenue through the development and sale of innovative medical devices aimed at enhancing the standard of care in venous disease treatment.
